Customizing treatments for deadly prostate cancer with tumor genomics

A new study is using genomic sequencing to develop customized treatments for men with castration-resistant prostate cancer, a progressive and incurable stage of prostate cancer, which no longer responds to hormone therapies that stop or slow testosterone production.

Read the whole article on Science Daily

More from Science Daily